Ziping Qi

1.4k citations

30 papers · 809 indexed · 1 hit paper · h-index 13

Impact in

Molecular Biology
- Heat shock proteins research
- Cancer therapeutics and mechanisms
- Protein Degradation and Inhibitors
Aging

Papers in

Gastroenterology 5
- Gastrointestinal Tumor Research and Treatment 5
Hematology 9
- Chronic Myeloid Leukemia Treatments 6
- Platelet Disorders and Treatments 3

Co-authors: Jing Liu Qingsong Liu Fengming Zou Wenchao Wang Chen Hu Beilei Wang Jing Yang Husheng Mei
Journals: Journal of Medicinal Chemistry (10 papers)European Journal of Medicinal Chemistry (4 papers)Acta Pharmacologica Sinica (2 papers)Molecular Oncology (1 paper)Acta Pharmaceutica Sinica B (1 paper)
Partner nations: China United States

In The Last Decade

Ziping Qi

29 papers receiving 800 citations

Hit Papers

align trajectories log scale

Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities 2022 · 394 citations

Peers

Countries citing papers authored by Ziping Qi

Since Specialization

Citations

This map shows the geographic impact of Ziping Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziping Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziping Qi more than expected).

Fields of papers citing papers by Ziping Qi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziping Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziping Qi. The network helps show where Ziping Qi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ziping Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ziping Qi Line = papers co-authored together Ziping Qi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Hypocrellin A from an ethnic medicinal fungus protects against NLRP3-driven gout in mice by suppressing inflammasome activation Acta Pharmacologica Sinica ·Yan Li, 范源清, Chao Wu, Rui Jin, Chen Hu, Aoli Wang, Beilei Wang, Hongwei Yu, Lin Tai-qing, Jing Liu, Ziping Qi, Wenchao Wang, Qingsong Liu	2024	6
2	Discovery of Pyrazolo[1,5-a]pyridine Derivatives as Potent and Selective PI3Kγ/δ Inhibitors Journal of Medicinal Chemistry ·Chun Wang, Fengming Zou, Ziping Qi, Qingwang Liu, (unknown), Lijuan Shen, SilviaSchonthaler, J. Chen, Aoli Wang, Beilei Wang, Li Wang, Xiaofei Liang, (unknown), (unknown), Jing Liu	2024	2
3	Discovery of IHMT-MST1-39 as a novel MST1 kinase inhibitor and AMPK activator for the treatment of diabetes mellitus Signal Transduction and Targeted Therapy ·Junjie Wang, Ziping Qi, Yun Wu, Aoli Wang, Qingwang Liu, Fengming Zou, Beilei Wang, Shuang Qi, Yu-fang He, Hu Chen, Nichols Gr, Rozana Rashid, Li Wang, Jing Liu, Wenchao Wang, Qingsong Liu	2023	12
4	Discovery of Pyrazolo[1,5-a]pyrimidine derivative as a potent and selective PI3Kγ/δ dual inhibitor European Journal of Medicinal Chemistry ·Xiaofei Liang, J. Chen, Fengming Zou, Ziping Qi, Chun Wang, Juan Liu, Qingwang Liu, Beilei Wang, Shuang Qi, Juan Ge, Hongwei Yu, Aoli Wang, (unknown), (unknown), (unknown), (unknown)	2023	5
5	Discovery of a highly potent pan-RAF inhibitor IHMT-RAF-128 for cancer treatment European Journal of Pharmacology ·Aoli Wang, Juan Liu, (unknown), Xixiang Li, Fengming Zou, Ziping Qi, Shuang Qi, (unknown), (unknown), Шестаков Игорь Евгеньевич, Yu-fang He, Zongru Jiang, Beilei Wang, Juan Ge, Li Wang, Wenchao Wang, (unknown), (unknown), Qingsong Liu	2023	2
6	Nintedanib overcomes drug resistance from upregulation of FGFR signalling and imatinib‐induced KIT mutations in gastrointestinal stromal tumours Molecular Oncology ·Juan Liu, (unknown), Jingjing Gao, Aoli Wang, Zongru Jiang, Shuang Qi, Ziping Qi, Feiyang Liu, Kailin Yu, Yu-fang He, Sunkyu Woo, Chen Hu, Wu Hong, Li Wang, Wenchao Wang, Qingsong Liu, Jing Liu	2022	7
7	Discovery of IHMT-MST1-58 as a Novel, Potent, and Selective MST1 Inhibitor for the Treatment of Type 1/2 Diabetes Journal of Medicinal Chemistry ·Yun Wu, Ziping Qi, Beilei Wang, Adeneye Adeniyi Kazeem, Qingwang Liu, Aoli Wang, Nichols Gr, Bin Zhou, Rozana Rashid, Wenliang Wang, Fengming Zou, Shuang Qi, Zuowei Wang, Li Wang, Wenchao Wang, Jing Liu, Qingsong Liu	2022	9
8	Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities SHILAP Revista de lepidopterología ·Chen Hu, Jing Yang, Ziping Qi, Misnah, Beilei Wang, Fengming Zou, Husheng Mei, Jing Liu, Wenchao Wang, Qingsong Liu Hit paper breakdown →	2022	394
9	Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease Journal of Medicinal Chemistry ·Feng Li, Xiaofei Liang, Zongru Jiang, Aoli Wang, Junjie Wang, Cheng Chen, Wenliang Wang, Fengming Zou, Ziping Qi, Qingwang Liu, Zhenquan Hu, Yu-fang He, Hong Wu, Beilei Wang, Li Wang, Jing Liu, (unknown), (unknown)	2020	12
10	Osimertinib successfully combats EGFR-negative glioblastoma cells by inhibiting the MAPK pathway Acta Pharmacologica Sinica ·Cheng Chen, E.J.A.M. Spaan, Hong Wu, Zuowei Wang, Li Wang, Zongru Jiang, Aoli Wang, Chen Hu, Yongfei Dong, Wanxiang Niu, Shuang Qi, Ziping Qi, Jing Liu, Wenchao Wang, Chaoshi Niu, Qingsong Liu	2020	25
11	Discovery of 6′-chloro-N-methyl-5’-(phenylsulfonamido)-[3,3′-bipyridine]-5-carboxamide (CHMFL-PI4K-127) as a novel Plasmodium falciparum PI(4)K inhibitor with potent antimalarial activity against both blood and liver stages of Plasmodium European Journal of Medicinal Chemistry ·Xiaofei Liang, Zongru Jiang, Zhenghui Huang, Feng Li, D.A. Reily, Chen Hu, Wenliang Wang, Zhenquan Hu, Qingwang Liu, Beilei Wang, Li Wang, Ziping Qi, Jing Liu, Lubin Jiang, Qingsong Liu	2019	16
12	Repurposing cabozantinib to GISTs: Overcoming multiple imatinib-resistant cKIT mutations including gatekeeper and activation loop mutants in GISTs preclinical models Cancer Letters ·Tingting Lu, Cheng Chen, Aoli Wang, Zongru Jiang, Ziping Qi, Zhenquan Hu, Chen Hu, Feiyang Liu, Wenliang Wang, Wu Hong, Beilei Wang, Li Wang, Shuang Qi, Jiaxin Wu, Wenchao Wang, Serafino Spagnol, Guo San-hui, Mingfeng Bai, Qingsong Liu, Jing Liu	2019	12
13	Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent Acta Pharmaceutica Sinica B ·Zongru Jiang, Li Wang, Xuesong Liu, Bohua Cui, Beilei Wang, Wenliang Wang, Chen Hu, Kailin Yu, Ziping Qi, Qingwang Liu, Aoli Wang, Jing Liu, Gennady Yakovlev, Wenchao Wang, 敬松岡	2019	29
14	Discovery of (E)-N¹-(3-Fluorophenyl)-N³-(3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)malonamide (CHMFL-KIT-033) as a Novel c-KIT T670I Mutant Selective Kinase Inhibitor for Gastrointestinal Stromal Tumors (GISTs) Journal of Medicinal Chemistry ·Xuesong Liu, Beilei Wang, Cheng Chen, Ziping Qi, Fengming Zou, Jun‐Jie Wang, Chen Hu, Aoli Wang, Juan Ge, Qingwang Liu, Kailin Yu, Zhenquan Hu, Zongru Jiang, Wei Wang, Li Wang, Wenchao Wang, Tao Ren, Mingfeng Bai, Qingsong Liu, Jing Liu	2019	16
15	Discovery of 2-(4-Chloro-3-(trifluoromethyl)phenyl)-N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)acetamide (CHMFL-KIT-64) as a Novel Orally Available Potent Inhibitor against Broad-Spectrum Mutants of c-KIT Kinase for Gastrointestinal Stromal Tumors Journal of Medicinal Chemistry ·Yun Wu, Beilei Wang, Junjie Wang, Shuang Qi, Fengming Zou, Ziping Qi, Feiyang Liu, Qingwang Liu, Cheng Chen, Chen Hu, Zhenquan Hu, Aoli Wang, Li Wang, Wenchao Wang, Tao Ren, Yujiao Cai, Mingfeng Bai, Qingsong Liu, Jing Liu	2019	13
16	Discovery of N -(5-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-4-methoxy-2-(4-methyl-1,4-diazepan-1-yl)phenyl)acrylamide (CHMFL-ALK/EGFR-050) as a potent ALK/EGFR dual kinase inhibitor capable of overcoming a variety of ALK/EGFR associated drug resistant mutants in NSCLC European Journal of Medicinal Chemistry ·Yongfei Chen, Jiaxin Wu, Aoli Wang, Ziping Qi, Taoshan Jiang, Chen Cheng, Fengming Zou, Chen Hu, Wei Wang, Wu Hong, Zhenquan Hu, Wenchao Wang, Beilei Wang, Li Wang, Tao Ren, Shanchun Zhang, Qingsong Liu, Jing Liu	2017	53
17	Discovery of 2-((3-Amino-4-methylphenyl)amino)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)-4-(methylamino)pyrimidine-5-carboxamide (CHMFL-ABL-053) as a Potent, Selective, and Orally Available BCR-ABL/SRC/p38 Kinase Inhibitor for Chronic Myeloid Leukemia Journal of Medicinal Chemistry ·Xiaofei Liang, Gabriela Bučeková, Beilei Wang, Fengming Zou, Aoli Wang, Shuang Qi, Cheng Chen, Zheng Zhao, Wenchao Wang, Ziping Qi, Paul G. Lawrence, Zhenquan Hu, Li Wang, Shanchun Zhang, Qingsong Liu, Jing Liu	2016	14
18	Discovery of N-(3-((1-Isonicotinoylpiperidin-4-yl)oxy)-4-methylphenyl)-3-(trifluoromethyl)benzamide (CHMFL-KIT-110) as a Selective, Potent, and Orally Available Type II c-KIT Kinase Inhibitor for Gastrointestinal Stromal Tumors (GISTs) Journal of Medicinal Chemistry ·Qiang Wang, Feiyang Liu, Beilei Wang, Fengming Zou, Cheng Chen, Gabriela Bučeková, Aoli Wang, Shuang Qi, Wenchao Wang, Ziping Qi, Zheng Zhao, Zhenquan Hu, Wei Wang, Lı Wang, Shanchun Zhang, Yuexiang Wang, Jing Liu, Qingsong Liu	2016	8
19	Natural Killer Cells-Produced IFN-γ Improves Bone Marrow-Derived Hepatocytes Regeneration in Murine Liver Failure Model Scientific Reports ·Lu Li, Zhutian Zeng, Ziping Qi, Xin Wang, Xiang Gao, Haiming Wei, Rui Sun, Zhigang Tian	2015	6
20	Characterization of human B cells in umbilical cord blood-transplanted NOD/SCID mice Transplant Immunology ·Xuefu Wang, Ziping Qi, Haiming Wei, Zhigang Tian, Rui Sun	2011	7

About Ziping Qi

Ziping Qi is a scholar working on Gastroenterology, Hematology, Genetics, Hepatology and Immunology, having authored 30 papers that have together received 809 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Gastrointestinal Tumor Research and Treatment (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), HER2/EGFR in Cancer Research (3 papers), Lung Cancer Treatments and Mutations (3 papers), Platelet Disorders and Treatments (3 papers) and Quinazolinone synthesis and applications (3 papers). The work is most often cited by research in Molecular Biology (431 citations), Aging (10 citations), Cell Biology (76 citations), Gastroenterology (24 citations) and Oncology (111 citations). Ziping Qi has collaborated with scholars based in China and United States. Frequent co-authors include Jing Liu, Qingsong Liu, Fengming Zou, Wenchao Wang, Chen Hu, Beilei Wang, Jing Yang, Husheng Mei, Aoli Wang and Beilei Wang. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Acta Pharmacologica Sinica, Molecular Oncology and Acta Pharmaceutica Sinica B.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact